Skip to content
BOLUS

Fund

Catalio Capital Management

Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.

Operations logged
8
Lead
4
New entries
3
Follow ons
1
Latest operation
24 September 2026
Sectors
Biotech, Medtech, Diagnostics

Operations

Date Company Stage Amount Role
24 Sept

United States, Biotech

Series C 75 M$ Participant
23 Sept

United Kingdom, Biotech

Series C 140 M$ Participant
23 Sept

United States, Biotech

Series D and later 311 M$ Lead
17 Sept

United States, Medtech

45 M$ Lead
15 Sept

United States

Series B 40 M$ Lead
03 Sept

United States, Biotech

Series B 60 M$ Existing investor
08 Aug

United States, Biotech

Series B 118 M$ Lead
07 Apr

United States, Diagnostics

Series B 97 M$ Participant
Co investors 77 funds crossed

Funds that appeared in the same rounds, in any capacity. Geographies logged: United States, United Kingdom.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).